While most segments of the lab market continue to grow at 5 percent per year, the molecular diagnostics market continues to grow at approximately 20 percent to an approximate total of $5.5 billion in 2008, according to Washington G-2 Reports’s estimates. This growth is expected to accelerate, with this area of lab testing estimated to value $8 billion by 2010, noted G-2’s Stephanie Murg, editor of the Diagnostic Testing & Technology Report, at a conference, Business & Financial Strategies for Molecular Diagnostics, held April 30 to May 2 in Cambridge, Massachusetts.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2008 - Table of Contents

LIR June 2008 (full PDF issue)

Prices Dropping on Some DTC Genetic Tests as SACGHS Urges Tighter Regs

G-2 Predicts Global Mol Dx Industry to Reach $5.5 Billion in 2008, $8 Billion by 2010

Quest, LabCorp Revenue/Requisition Metrics Strengthen in Q1

LabCorp’s Partners With Siemens, Acquires Louisiana Lab

Cost and Profit Analysis Is Key to Capturing Revenue Potential of Mol Dx Lab

Q1 08 Lab Benchmark Data Reveal Psychemedics Still a Leader, Enzo Posts Gains

JVHL Teams With Clarient to Expand Cancer AP Menu

Orchid Cellmark Wins $30 Million Forensic Testing Contract in U.K.

Lab Stocks Continue to Post Gains in May, up 8% Over 5 Weeks

Economic Development Incentives Fuel Genzyme Genetics’s Staff Expansion in Santa Fe